Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence?

Figure 1

Changes in hemoglobin and IgA levels. BDR: bortezomib, dexamethasone, and rituximab combination therapy. CAD: cold agglutinin disease.